Osimertinib + Chemotherapy Improves Survival in Advanced… : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
Fuzuloparib with or without apatinib provided superior PFS benefit vs chemotherapy in HER2– metastatic breast cancer harboring germline BRCA1/2 mutations.
PHILADELPHIA (May 8, 2024) — On April 26, 2024, Fox Chase Cancer Center welcomed staff and faculty from Temple Health to the 10th Annual Cultural…
The American Cancer Society plans to follow 100,000 healthy black women for 30 years in the largest-of-its kind study into the demographic’s long- term health…
A new study suggests that starting a patient on preferred targeted therapy within 1 year of metastatic non-small cell lung cancer diagnosis can still improve…
This site uses cookies. By continuing to use our website, you are agreeing to our privacy
s could offer a valuable orientation for long COVID-related research and clinical care. This retrospective cohort study aimed to determine whether having a COPC predicts…
An abstract is unavailable.
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
f eGFR laboratory data and case report forms had not been completed. This resulted in a small number of kidney composite events and a nominal…
Mohamad Mohty, MD, PhD, highlights key takeaways from the 50th Annual EMBT Meeting, focusing on ongoing efforts within the GVHD treatment arena.